Counterpoint Mutual Funds’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-53,972
Closed -$7.29M – 330
2026
Q2
$7.29M Buy
+53,972
New +$9.5M 0.72% 33
2024
Q4
– Sell
-3,137
Closed -$297K – 283
2024
Q3
$297K Buy
+3,137
New +$278K 0.06% 127
2023
Q2
– Sell
-380
Closed -$84K – 293
2023
Q1
$84K Buy
+380
New +$93.6K 0.07% 326
2022
Q4
– Sell
-379
Closed -$100K – 313
2022
Q3
$100K Buy
+379
New +$96.4K 0.24% 192

Other funds holding ALB

Counterpoint Mutual Funds's ALB Position: Q3 2026 in Review

Counterpoint Mutual Funds sold out of Albemarle (ALB) in Q3 2026, closing a stake of 53,972 shares — an estimated $7.29M sold.

Counterpoint Mutual Funds first reported a position in ALB in Q3 2022 and held it in 4 quarters. The position peaked at $7.29M in Q2 2026. 859 funds tracked by Wall St. Rank hold ALB as of Q3 2026.

  • Counterpoint Mutual Funds reported no remaining Albemarle position as of Q3 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 53,972 Albemarle shares in Q3 2026, an estimated $7.29M.
  • Counterpoint Mutual Funds first reported a position in Albemarle in Q3 2022 and held it in 4 quarters.
  • Counterpoint Mutual Funds's Albemarle position peaked at $7.29M in Q2 2026.
  • 859 funds tracked by Wall St. Rank held Albemarle as of Q3 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2026, filed 16 Oct 2026.